Skip to main content
HCONRES 380 107th Congress House Health Access to health care Blood diseases Child health Congress Congressional reporting requirements Genetic counseling Genetic screening Health education Hemophilia Hormone replacement therapy Hysterectomy Medical research Medical screening Medical tests Menstruation Preventive medicine Science, Technology, Communications Women's health

Expressing the sense of the Congress regarding women with bleeding disorders.

Introduced: April 17, 2002 See on congress.gov
This resolution expired with the 107th Congress
It was not agreed to before the 107th Congress (2001–2002) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
Apr 23, 2002
Referred to the Subcommittee on Health.
Apr 17, 2002
Referred to the House Committee on Energy and Commerce.
Apr 17, 2002
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Expresses the sense of Congress that (1) physicians should screen all adolescents and all adult women presenting with severe menorrhagia for von Willebrand's disease; (2) hysterectomy for excessive menstrual bleeding should not be performed without the consideration of a bleeding disorder; (3) referral of women with bleeding disorders to a federally sponsored hemophilia treatment center is critical to comprehensive treatment; (4) physicians should be encouraged to conduct clotting factor assays for carrier diagnosis and to facilitate genotyping of the disorder and patients should be referred for genetic counseling when appropriate; (5) patient advocate organizations and medical specialty societies should continue to collaborate on public education campaigns to educate women about bleeding disorders; (6) the Federal Government has a responsibility to further research on von Willebrand's disease and improve access to hemophilia treatment centers for all individuals with bleeding disorders; (7) the Director of the National Institutes of Health should develop a 5-year research plan concerning women with bleeding disorders; and (8) the Director of the Centers for Disease Control and Prevention should continue to improve outreach, treatment, and prevention of the complications of women's bleeding disorders.
What's happening now April 23, 2002

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H. Con. Res. 380: Expressing the sense of the Congress regarding women with bleeding disorders.. 107th Congress. Open America. https://openamerica.io/bill/107-HCONRES-380/
MLA
"H. Con. Res. 380: Expressing the sense of the Congress regarding women with bleeding disorders.." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HCONRES-380/.
Bluebook (legal)
H. Con. Res. 380, 107th Cong. (2026), https://openamerica.io/bill/107-HCONRES-380/.
Markdown link
[H. Con. Res. 380: Expressing the sense of the Congress regarding women with bleeding disorders.](https://openamerica.io/bill/107-HCONRES-380/)
Report a problem